PharmaVigil Automates PV Literature Activities with PubHive

PubHive Ltd., a scientific software company serving enterprise life science companies, and European contract research organization (CRO) PharmaVigil today announced that PharmaVigil has secured a software subscription license to PubHive’s validated drug safety and pharmacovigilance (DSPV) software platform. By adopting the PubHive Navigator software platform, PharmaVigil will automate many safety-related tasks involving literature, while boosting Good Vigilance Practice (GVP) compliance and audit readiness for the benefit of its manufacturing clients.

“So many of the safety software solutions on the market charge a lot, promise a lot, but do not deliver a lot,” said Maja Barac, M.clin.pharm., CEO, EU QPPV, LPPV, and RA consultant at PharmaVigil d.o.o. “PharmaVigil decided to switch to PubHive’s drug safety and pharmacovigilance software platform since it is the only automated solution on the market that covers end-to-end processes across both global and local literature, and because of PubHive’s flexibility both in its solution as well as the ease of doing business that it offers to growing companies like PharmaVigil.”

“PubHive is honored that PharmaVigil has joined the growing number of life science companies that are turning to PubHive as their primary enterprise literature software provider,” added Raj Vaghela, PubHive President and Chief Executive Officer. “We look forward to supporting PharmaVigil and the important services that their team provides to manufacturers of veterinary and human medicinal products.”

PubHive Ltd. is a cloud-based software company with the mission to make healthier scientific literature and safety information pathways for life science companies across all stages of the commercialization lifecycle – from discovery to post-market. PubHive Navigator™, the company’s scientific software platform, optimizes existing business processes and automates repetitive work for life science companies. PubHive Navigator features platform modules for drug safety and pharmacovigilance activities, systematic literature review projects, and scientific literature workflows managed by teams in clinical and regulatory affairs, medical affairs, medical information, and discovery research.

PharmaVigil d.o.o. was founded in 2013 with the aim of providing complete, high-quality consulting services in drug development and safety as well as the application of good business practices in manufacturing, control and distribution of medicinal products, and oversight of drug safety profiles both during and after marketing authorization approvals. PharmaVigil offers notification and registration services for food supplements and medicines, regulatory services for all types of medical devices, QPPV and pharmacovigilance services, and translation services. The company currently offers services in countries such as Croatia, Kosovo, Albania, Bosnia and Herzegovina, Romania, Slovakia, Czech Republic, Turkey, Montenegro, Bulgaria, Serbia, Northern Macedonia.

To learn more about PubHive and the PubHive Navigator cloud software platform, visit the PubHive website at pubhive.com. To learn more about PharmaVigil, visit the company website at pharmavigil.hr.

About PubHive

PubHive Ltd. is a cloud-based software company with a mission to make healthier scientific literature and safety information pathways for life science companies across all stages of the commercialization lifecycle – from discovery to post-market. PubHive Navigator, the company’s scientific workflow management platform, optimizes existing business processes and automates repetitive work for teams in drug safety and pharmacovigilance (DSPV), medical affairs, market access and health economics and outcomes research (HEOR), research and development, clinical affairs, regulatory affairs, information management, and other divisions. Powered by a proprietary Omni-Loop Artificial Intelligence (AI)™ engine, PubHive Navigator is the only 'fit for purpose' one-stop scientific workflow automation platform today, distinguishing itself through flexible end-to-end workstreams and intuitive interfaces that make literature handling quick and easy.

About PharmaVigil